Sialadenosis in bulimia. A new treatment.
To see whether a cholinomimetic medication would help resolve the parotid gland enlargement associated with self-induced vomiting in bulimic patients. The medication was administered on an inpatient eating disorder unit to bulimic patients with refractory sialadenosis. Pilocarpine hydrochloride drops were administered orally at a dosage of 1.25 to 5.0 mg/d until the parotid gland enlargement was significantly reduced. There was a marked diminution in the size of the parotid gland enlargement. Pilocarpine has proved to be beneficial in the treatment of sialadenosis in bulimic patients.